Data integrity – Page 19

Step-by-Step Guide to Managing Hybrid Deviation Investigation Files Under ALCOA+ Expectations

Managing Hybrid Deviation Investigation Files for ALCOA+ Compliance In the pharmaceutical industry, the integration of hybrid paper-electronic systems can often lead to deviations that challenge data integrity and compliance requirements.…

How to Avoid Data Omission in GMP Documentation

Strategies to Mitigate Data Omission in GMP Documentation In the highly regulated pharmaceutical environment, data omission in GMP documentation poses significant risks to compliance and product integrity. In this case…

Why Hybrid Change Control Records Happens and How QA Teams Should Control It

Managing Hybrid Change Control Records: Practical Solutions for QA Teams In the pharmaceutical industry, maintaining data integrity is paramount, especially when dealing with hybrid paper-electronic GMP records. A common frustration…

GDP Requirements for Manual Calculations and Transcriptions

Addressing GDP Compliance Challenges in Manual Calculations and Transcriptions In today’s pharmaceutical manufacturing and quality control environments, ensuring that manual calculations and transcriptions meet GDP compliance is vital for maintaining…

Inspection-Ready Approach to Hybrid Training Record Risks in Pharmaceutical Operations

Addressing the Risks Associated with Hybrid Training Records in Pharmaceutical Operations In the pharmaceutical industry, the integration of hybrid training records, which combine traditional paper-based systems with electronic documentation, presents…

How to Maintain Legible and Permanent GMP Records

Effective Strategies for Ensuring Legible and Permanent GMP Records In pharmaceutical manufacturing, maintaining legible and permanent records is crucial for compliance with Good Manufacturing Practices (GMP). Documentation errors can lead…

Paper Corrections and Audit Trails: Root Causes, GMP Risks, and CAPA Controls

Understanding Paper Corrections and Audit Trails in Hybrid Systems: Addressing GMP Risks In the world of pharmaceutical manufacturing, hybrid paper and electronic systems have become commonplace for managing Good Manufacturing…

Good Documentation Practices for OOS and Deviation Investigations

Effective Documentation Strategies for Out-of-Specification Results and Investigation Deviations In pharmaceutical manufacturing and quality control, the occurrence of out-of-specification (OOS) results or deviations can create significant challenges for laboratories and…

How to Prevent Electronic Data with Paper Approval in Hybrid Paper–Electronic Systems

Strategies for Managing Electronic Data with Paper Approvals in Hybrid Paper–Electronic Systems In the evolving landscape of pharmaceutical manufacturing, the integration of hybrid paper–electronic systems can present unique challenges, particularly…

GDP Training Effectiveness: How to Prove People Can Document Correctly

Ensuring Effective GDP Training: Strategies for Proving Documentation Competence In pharmaceutical manufacturing, maintaining compliance with Good Documentation Practices (GDP) is critical to ensuring data integrity and regulatory adherence. A common…

Step-by-Step Guide to Managing Document Control for Hybrid Forms Under ALCOA+ Expectations

Step-by-Step Management of Document Control for Hybrid Systems in Accordance with ALCOA+ Principles In today’s pharmaceutical landscape, managing hybrid paper-electronic systems presents unique challenges, particularly with regards to document control…

How to Handle Late Entries in GMP Documentation

Navigating Late Entries in GMP Documentation: A Comprehensive Case Study In a highly regulated pharmaceutical environment, the accurate and timely completion of documentation is paramount. When discrepancies arise due to…